Log In
Print this Print this

AMG 747

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionSmall molecule inhibitor of glycine transporter type 1 (GlyT1)
Molecular Target Glycine transporter type 1 (GlyT1) (SLC6A9)
Mechanism of ActionGlycine transporter type 1 (GlyT1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationSchizophrenia
Indication DetailsTreat cognitive deficits associated with schizophrenia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today